ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 1

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. The Effect of Telomerase Inhibition on NK Cell Activity in Acute Myeloid Leukemia

Khadijeh Dizaji Asl , Ali Rafat , Ali Akbar Movassaghpour , Hojjatollah Nozad Charoudeh , Hamid Tayefi Nasrabadi*

Adv Pharm Bull. 2023;13(1): 170-175. doi: 10.34172/apb.2023.018

PMCID: PMC9871272 PMID: 36721807

Article

PDF

Full Text

XML

Cited By:

Original Article

2. Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric Adenocarcinoma

Maryam Samareh-Salavatipour , Shirin Tavakoli , Maryam Barkhordar, Iman Seyhoun*, Nasim Vousooghi, Mohammad Vaezi, Afshin Ghaderi, Tahereh Bakhtiari, Ardeshir Ghavamzadeh, Javad Verdi* , Mohammad Ahmadvand*

Adv Pharm Bull. 2025;15(1): 143-153. doi: 10.34172/apb.43859

Article

PDF

XML

Cited By:

Research Article

3. Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma

Shirin Tavakoli , Maryam Samareh-Salavati, Shahrokh Abdolahi, Javad Verdi, Iman Seyhoun, Nasim Vousooghi, Mohammad Vaezi, Afshin Ghaderi, Ardeshir Ghavamzadeh, Maryam Barkhordar* , Mohammad Ahmadvand*

Adv Pharm Bull. 2024;14(4): 918-926. doi: 10.34172/apb.43869

Article

PDF

Full Text

XML

Cited By: